Items where authors include "Rigby, W"

Article

Conaghan, P orcid.org/0000-0002-3478-5665, Cohen, S, Burmester, G et al. (11 more authors) (2022) Benefit-Risk Analysis of Upadacitinib compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis. Rheumatology and Therapy, 9 (1). pp. 191-206. ISSN 2198-6576

Conaghan, PG orcid.org/0000-0002-3478-5665, Mysler, E, Tanaka, Y et al. (9 more authors) (2021) Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program. Drug Safety, 44. pp. 515-530. ISSN 0114-5916

Smolen, JS, Pangan, AL, Emery, P orcid.org/0000-0002-7429-8482 et al. (9 more authors) (2019) Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study. The Lancet, 393 (10188). pp. 2303-2311. ISSN 0140-6736